Italian drug discovery specialist Axxam and German AI firm Molecular Health have struck a strategic alliance aimed at ...

US clinical-stage biotech Vigil Neuroscience (Nasdaq: VIGL) today announced a disappointing update on the Phase II IGNITE ...

Neuropsychiatric disorders specialist Alto Neuroscience, has entered into an asset purchase agreement with Chase Therapeutics ...

Danish dermatology specialist LEO Pharma has appointed Helle Hedegaard Juhl as executive vice president for global people and ...

US biotech BioAge Labs (Nasdaq: BIOA) is expanding its obesity pipeline just months after shelving its lead drug in the ...

US clinical-stage biotech Sagimet Biosciences (Nasdaq: SGMT) today reported denifanstat met all primary and secondary ...

The European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature ...

The American medicines regulator has committed to reviewing the safety of the abortion pill mifepristone, amid renewed ...

India’s Zydus Lifesciences (BOM:532321) announced that it has entered into a definitive agreement with Agenus (Nasdaq: AGEN) ...

US pharma major Eli Lilly (NYSE: LLY) has struck a deal worth up to $870 million with Swedish biotech Camurus (Nasdaq ...

The American medicines regulator has approved Bayer’s Nubeqa (darolutamide) for broader use in patients with metastatic ...

The European Commission (EC) has approved Adcetris (brentuximab vedotin) in combination with etoposide, cyclophosphamide, ...